Comparative effectiveness of bisoprolol and carvedilol among patients receiving maintenance hemodialysis

BACKGROUND: Despite widespread use, there is no trial evidence to inform β-blocker’s (BB) relative safety and efficacy among patients undergoing hemodialysis (HD). We herein compare health outcomes associated with carvedilol or bisoprolol use, the most commonly prescribed BBs in these patients. METH...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Kidney J
Asıl Yazarlar: Wu, Ping-Hsun, Lin, Yi-Ting, Liu, Jia-Sin, Tsai, Yi-Chun, Kuo, Mei-Chuan, Chiu, Yi-Wen, Hwang, Shang-Jyh, Carrero, Juan-Jesus
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2021
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7986334/
https://ncbi.nlm.nih.gov/pubmed/33779636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfaa248
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller